Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions
- PMID: 21881602
- PMCID: PMC3186899
- DOI: 10.1038/cddis.2011.80
Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions
Abstract
Malignant gliomas contain a population of self-renewing tumorigenic stem-like cells; however, it remains unclear how these glioma stem cells (GSCs) self-renew or generate cellular diversity at the single-cell level. Asymmetric cell division is a proposed mechanism to maintain cancer stem cells, yet the modes of cell division that GSCs utilize remain undetermined. Here, we used single-cell analyses to evaluate the cell division behavior of GSCs. Lineage-tracing analysis revealed that the majority of GSCs were generated through expansive symmetric cell division and not through asymmetric cell division. The majority of differentiated progeny was generated through symmetric pro-commitment divisions under expansion conditions and in the absence of growth factors, occurred mainly through asymmetric cell divisions. Mitotic pair analysis detected asymmetric CD133 segregation and not any other GSC marker in a fraction of mitoses, some of which were associated with Numb asymmetry. Under growth factor withdrawal conditions, the proportion of asymmetric CD133 divisions increased, congruent with the increase in asymmetric cell divisions observed in the lineage-tracing studies. Using single-cell-based observation, we provide definitive evidence that GSCs are capable of different modes of cell division and that the generation of cellular diversity occurs mainly through symmetric cell division, not through asymmetric cell division.
Figures
References
-
- Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–466. - PubMed
-
- Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, Colman SM, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469:356–361. - PubMed
-
- Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821–5828. - PubMed
-
- Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401. - PubMed
-
- Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 2002;39:193–206. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS054276/NS/NINDS NIH HHS/United States
- R01 CA116659/CA/NCI NIH HHS/United States
- F30 NS063496/NS/NINDS NIH HHS/United States
- CA151522/CA/NCI NIH HHS/United States
- F32 CA142159/CA/NCI NIH HHS/United States
- CA129958/CA/NCI NIH HHS/United States
- R01 CA151522/CA/NCI NIH HHS/United States
- CA154130/CA/NCI NIH HHS/United States
- CA116659/CA/NCI NIH HHS/United States
- R21 NS063057/NS/NINDS NIH HHS/United States
- R01 CA129958/CA/NCI NIH HHS/United States
- R01 NS054276/NS/NINDS NIH HHS/United States
- R01 CA154130/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
